Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Ig gamma-4 Chain C Region Mouse anti-Human, Clone: rIGHG4/1345, Novus Biologicals™

Ig gamma-4 Chain C Region Mouse anti-Human, Clone: rIGHG4/1345, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

$268.00

Specifications

Antigen Ig gamma-4 Chain C Region
Clone rIGHG4/1345
Concentration 0.2 mg/ml
Dilution Immunohistochemistry-Paraffin 1-2 ug/ml
Applications Immunohistochemistry (Paraffin)
View More Specs

Products 1
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NB122338
SDP
View Documents
View Product Certificates
View Alternatives and Save Up to
Novus Biologicals
NBP30743220UG 		20 μg
Each of 1 for $268.00
Only null left
Add to Cart
 
Description

Description

Ig gamma-4 Chain C Region Monoclonal specifically detects Ig gamma-4 Chain C Region in Human samples. It is validated for Immunohistochemistry-Paraffin.
Specifications

Specifications

Ig gamma-4 Chain C Region
0.2 mg/ml
Immunohistochemistry (Paraffin)
Unconjugated
Mouse
Human
IGHG4, mmunoglobulin heavy constant gamma 4, mmunoglobulin heavy constant gamma 4 (G4m marker)
Recombinant human Ig gamma-4 Chain C Region fragment
Primary
Store at 4°C.
rIGHG4/1345
Immunohistochemistry-Paraffin 1-2 ug/ml
Monoclonal
Purified
RUO
10 mM PBS with 0.05% BSA
3503
IgG1 κ
Protein A or G purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.